Case report on novel mutation in SPAST gene in Polish family with spastic paraplegia.
Clinical phenotype
Hereditary spastic paraplegia
Novel mutation
SPAST
Journal
BMC neurology
ISSN: 1471-2377
Titre abrégé: BMC Neurol
Pays: England
ID NLM: 100968555
Informations de publication
Date de publication:
14 Dec 2019
14 Dec 2019
Historique:
received:
03
10
2019
accepted:
08
12
2019
entrez:
16
12
2019
pubmed:
16
12
2019
medline:
19
3
2020
Statut:
epublish
Résumé
Hereditary spastic paraplegia is a large group of degenerative, neurological disorders characterized by progressive lower limb spasticity and weakness. The disease was investigated precisely but still clinicians often make incorrect or late diagnosis. Our aim was to investigate the genetic background and clinical phenotype of spastic paraplegia in large Polish family. A 37 years old woman presented with 4-year history of walking difficulties. On neurological examination, she had signs of upper motor lesion in lower extremities. She denied sphincter dysfunction and her cognition was normal. Her family history was positive for individuals with gait problems. The initial diagnosis was familial spastic paraplegia. Genetic testing identified a novel mutation in SPAST gene. All available family members were examined and had genetic testing. The same mutation in SPAST gene was identified in other affected family members. All patients caring the mutation presented with different phenotypes. This study presents a family with spastic paraplegia due to a novel mutation c.1390G›T(p.Glu464Term) in SPAST gene. Affected individuals showed a range of phenotypes that varied in their severity. This case report demonstrates, the signs of hereditary spastic paraplegia can be often misdiagnosed with other diseases. Therefore genetic testing should always be considered in patients with lower limb spasticity and positive family history in order to help to establish the correct diagnosis.
Sections du résumé
BACKGROUND
BACKGROUND
Hereditary spastic paraplegia is a large group of degenerative, neurological disorders characterized by progressive lower limb spasticity and weakness. The disease was investigated precisely but still clinicians often make incorrect or late diagnosis. Our aim was to investigate the genetic background and clinical phenotype of spastic paraplegia in large Polish family.
CASE PRESENTATION
METHODS
A 37 years old woman presented with 4-year history of walking difficulties. On neurological examination, she had signs of upper motor lesion in lower extremities. She denied sphincter dysfunction and her cognition was normal. Her family history was positive for individuals with gait problems. The initial diagnosis was familial spastic paraplegia. Genetic testing identified a novel mutation in SPAST gene. All available family members were examined and had genetic testing. The same mutation in SPAST gene was identified in other affected family members. All patients caring the mutation presented with different phenotypes.
CONCLUSION
CONCLUSIONS
This study presents a family with spastic paraplegia due to a novel mutation c.1390G›T(p.Glu464Term) in SPAST gene. Affected individuals showed a range of phenotypes that varied in their severity. This case report demonstrates, the signs of hereditary spastic paraplegia can be often misdiagnosed with other diseases. Therefore genetic testing should always be considered in patients with lower limb spasticity and positive family history in order to help to establish the correct diagnosis.
Identifiants
pubmed: 31837705
doi: 10.1186/s12883-019-1561-6
pii: 10.1186/s12883-019-1561-6
pmc: PMC6911268
doi:
Substances chimiques
Adenosine Triphosphatases
EC 3.6.1.-
Spastin
EC 3.6.4.3
SPAST protein, human
EC 5.6.1.1
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
322Références
J Neurol Sci. 2012 Jul 15;318(1-2):1-18
pubmed: 22554690
J Neurol Neurosurg Psychiatry. 2008 May;79(5):606-7
pubmed: 17971434
Brain. 2015 Sep;138(Pt 9):2471-84
pubmed: 26094131
Genet Med. 2015 May;17(5):405-24
pubmed: 25741868
Sci Rep. 2019 Oct 8;9(1):14412
pubmed: 31594988
JAMA Neurol. 2013 Jun;70(6):746-55
pubmed: 23609960